Psychedelics and Neurodegeneration
Research is emerging on the potential of psychedelics like psilocybin and ibogaine to treat neurodegenerative diseases such as Alzheimer's and Parkinson's. A notable study involving former Navy SEALs showed significant improvements in traumatic brain injury symptoms after ibogaine treatment. Despite the promising findings, a lack of funding hampers further exploration into these groundbreaking therapies, but future investments could unlock new possibilities for mental health and brain health.In this clip
From this podcast
LONGEVITY with Nathalie Niddam
The Truth About Microdosing: Psychedelics, Healing, and Mental Wellness with Paul Austin | Ep #295
Related Questions